Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint=true and openWorldHint=false, so the safety profile is covered. The description adds real value beyond them by disclosing the pricing model (free daily allowance, then $0.02 USDC via x402 or 1 credit with X-API-KEY), which affects whether an agent should call it. It still says nothing about payload shape, result size, or empty-result behavior.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Is the description appropriately sized, front-loaded, and free of redundancy?

Two short fragments with no filler; the billing caveat is compact and parenthetical. The structure is slightly off-balance because roughly half the text is payment mechanics while the actual purpose phrase is truncated.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a read-only, single-param lookup with no output schema, the agent still lacks a statement of what comes back (trial rows, regimen details) and how this differs from get_trial_landscape and get_dossier. The payment disclosure is a genuine completeness win, but the retrieval contract remains implicit.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

With one parameter at 100% schema description coverage, the schema already documents 'slug' as a peptide slug. The description adds no further meaning about slug format, resolution behavior, or what happens for an unknown slug. Baseline 3 applies when the schema does the documentation work.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Does the description clearly state what the tool does and how it differs from similar tools?

"Clinical/preclinical study rows and published regimen" names the resource but is a sentence fragment with no verb, so it never states that it retrieves trial data for a given peptide. It is distinguishable from get_adverse_events or get_regulatory by topic, but the boundary with get_trial_landscape and get_dossier is left unaddressed.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Does the description explain when to use this tool, when not to, or what alternatives exist?

There is no when-to-use guidance at all: no prerequisites, no conditions, and no mention of any sibling such as get_trial_landscape or get_dossier. The only contextual statement is about billing, which tells the agent nothing about selection.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.